Literature DB >> 1665466

Serum and erythrocyte levels of magnesium in microcytosis: comparison between heterozygous beta-thalassemia and sideropenic anemia.

V Abbasciano1, G Bader, L Graziano, D Mazzotta, G Vecchiatti, C Guglielmini, S Sartori.   

Abstract

In thalassemia erythrocyte cation permeability is increased, but the increment in ATPase-dependent cation pumps maintains normal concentrations of Ca++, Na+ and K+. In this study we investigated erythrocyte concentrations of Mg++ in heterozygous beta-thalassemia and in microcytic sideropenic anemia. Twenty-five healthy controls, 40 heterozygous beta-thalassemics and 25 patients with sideropenic anemia were studied. Erythrocyte Mg++ was assayed either by atomic absorption or by standard laboratory methods. Erythrocyte Mg++ was significantly lower in the beta-thalassemia group than in the other two groups (p less than 0.001). Serum magnesium was significantly lower in sideropenic anemia patients than in beta-thalassemics and in controls (p less than 0.01), whereas these latter two groups showed similar values. Our results suggest that the increment in ATPase-dependent cation pumps is not sufficient to maintain normal erythrocyte Mg++ concentrations in heterozygous beta-thalassemia. In sideropenic anemia cation permeability is not increased, therefore erythrocyte Mg++ is normal. Low serum Mg++ levels in sideropenic anemia could be explained by a primary Mg++ deficit associated with sideropenia.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1665466

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  2 in total

1.  Changes in the concentrations of plasma and erythrocyte magnesium and of 2,3-diphosphoglycerate during a period of aerobic training.

Authors:  A Resina; M Brettoni; L Gatteschi; P Galvan; F Orsi; M G Rubenni
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1994

Review 2.  Oxidative stress and β-thalassemic erythroid cells behind the molecular defect.

Authors:  Lucia De Franceschi; Mariarita Bertoldi; Alessandro Matte; Sara Santos Franco; Antonella Pantaleo; Emanuela Ferru; Franco Turrini
Journal:  Oxid Med Cell Longev       Date:  2013-09-24       Impact factor: 6.543

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.